Do GLP-1 Medicines Stop Working? Causes and Fixes (October 2026)

01 · The core answer

Does a GLP-1 stop working, or does progress just slow?

For most people, progress slows rather than the medicine stopping. ¹¹ Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight.

That matters because a plateau and a real loss of effect need different responses. A plateau is managed with a review of habits and dose. A genuine lack of response is judged over a longer period, on the highest dose you can tolerate, by your prescriber. If you want a deeper look at this question for one medicine, our guide on whether Mounjaro stops working goes through it in more detail.

02 · Your next move

What to do when your GLP-1 seems to have stopped working

Start with the licensed, low-risk checks before you consider anything else. Work through them in order and write down what you find, because your prescriber can act on specifics far better than on "it stopped working".

• Confirm which dose you are on and how long you have been on it.
• Check you have not missed or delayed doses, and that pens are stored properly.
• Review food intake honestly, including drinks and snacks.
• Protect protein and keep active, and look at sleep and alcohol.
• Book a review and ask whether a dose step-up is appropriate if you are not yet at the maximum.

If you are being treated through our service, the aftercare team can help with monthly reviews and dose decisions. If you are new to treatment and want to understand where it starts, our weight loss clinic explains the process, and the Mounjaro pen page shows current prices.

03 · Why plateaus happen

Why weight loss plateaus on a GLP-1

Plateaus happen because the body adapts as weight falls, so the same routine produces less change than it did at the start. ¹¹

Mounjaro manages weight, but it does not cure the biology behind it. That is why the effect on appetite is something you keep using, not a one-off reset. It is also why a stall can feel like the medicine fading when it is really the body defending a new, lower weight.

The headline trial results show how gradual this process is. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. ² These are trial averages and individual results vary. Averages built up over many months, not in a straight line, so a flat patch is part of the picture for many people.

Judge progress by the trend across weeks, not by a single weigh-in. Early loss includes water weight, and day-to-day readings move for reasons unrelated to fat. ¹

04 · Dose may be too low

When the dose is the issue

If appetite control feels weaker, the dose you are on may simply not be the one that works for you yet. Everyone starts Mounjaro on 2.5mg once a week, and this starting dose is about letting your body adjust, not about weight loss itself. ¹

After the starting phase the dose rises to 5mg, and can then step up in 2.5mg stages (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it. Steps are taken after at least 4 weeks on each dose. Many people settle at a maintenance dose of 5mg, 10mg or 15mg. Higher is not automatically better, and your prescriber guides the pace. ¹

This is why a slow first few months does not predict failure. Most people are still on the lower rungs of the ladder at that stage, and the dose you respond to may still be ahead of you. ² Our related guide on how long before Mounjaro seems to fade covers timing in more depth.

If you are already on the top dose and still stalled, the next conversation is a review of response rather than a bigger dose, because the licensed ceiling is 15mg.

05 · Habits and routine

Habits that quietly undo progress

Food habits drift over the months, and that is one of the commonest reasons a GLP-1 appears to weaken. Within the licence, the responses to a plateau are to review food intake honestly because portions drift back up, protect protein and activity, and check the basics such as sleep and alcohol. ¹¹

Treatment is designed to work alongside a reduced-calorie diet and increased physical activity, not instead of them. When appetite is quieter, it is easy to eat smaller meals but add back liquid calories, snacks or alcohol without noticing. A short spell of logging food, or using a companion tracker such as our free GLPTrackr app, can show where the drift is.

Protein and movement matter because they support the body as weight falls. Keep activity that you can sustain rather than a short burst you will drop. Sleep and alcohol are worth checking, as both can push appetite and choices in the wrong direction.

A plateau is not a reason to double doses or add unlicensed products. ¹¹ If the habits check finds nothing, that is useful information to bring to your prescriber.

06 · Pen and injection checks

Check your pen, storage and injection routine

Practical mistakes can make treatment seem weaker, so check the pen routine before assuming the medicine has failed. Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C. ¹³

Keep the pen cap on to protect it from light, and never use a pen that has been frozen. Unopened pens should stay in the fridge and keep until the printed expiry date. If an unopened pen has been out of the fridge, check with the pharmacy before using it rather than relying on a remembered day limit, because figures circulating online often come from other countries' labels. ¹³

Mounjaro is injected under the skin once a week, on the same day each week, at any time of day, with or without food. Rotate the site each dose. ¹ There is no best time of day, so what matters is consistency.

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time. If more than 4 days have passed, skip it and take the next one on your normal day, and never take two doses within 3 days of each other. ¹ Repeated gaps can leave appetite control feeling patchy.

07 · Stopping and breaks

What happens if you take a break or stop

Stopping a GLP-1 usually leads to weight regain on average, so any break should be planned. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. ¹⁴ Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears. ¹ That means appetite changes can take a while to return, and the full effect of a break only shows over the following weeks.

People ask whether a short course is enough or whether treatment is for life. Treatment is ongoing weight management, reviewed by your prescriber, so the plan depends on your response, your goals and your clinician's advice. Our guide on what happens after a year on Mounjaro looks at longer-term use.

08 · What not to do

Shortcuts to avoid when progress stalls

Mounjaro is a once-weekly medicine, with blood levels designed around a 7-day cycle. ¹

Altering doses outside the licence means unknown dosing accuracy and no safety data. ¹

Talk to your clinical team rather than self-adjusting.

Low-cost supplements sold with dramatic weight-loss claims have no clinical oversight and are not a replacement for a licensed medicine. If you are curious about non-injectable options, our guide on whether orlistat stops working explains how that medicine compares on this question.

09 · Formal response review

When your prescriber formally reviews response

A formal review point exists so that a lack of response is judged properly, not on a bad fortnight. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you. ⁴

The review is based on the highest dose you can tolerate. Someone held at a lower dose because of side effects is in a different position from someone at the top of the ladder. Your prescriber weighs both.

Beyond the scales, trial participants saw average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels. These are trial-average secondary outcomes, not promises. ² So a scale that has stopped moving does not tell the whole story, and your clinician can look at the wider picture.

If a different licensed medicine might suit you better, that is a conversation for your prescriber. Wegovy is a separate semaglutide medicine, and you can read about the Wegovy pen, but switching is a clinical decision rather than a quick fix. NHS access to Wegovy runs through specialist weight-management services, so ask your GP.

Report any new or worrying symptoms through the Yellow Card scheme. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of the skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. For more reading on specific timings, see our guides on whether Mounjaro eventually stops working and changes over time.